+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Diabetes Drugs Markets in China

  • PDF Icon

    Report

  • 214 Pages
  • August 2024
  • Region: China
  • AMID Co
  • ID: 836812

China's demand for Diabetes Drugs will continue to grow at 7% by 2033.

China's demand for Diabetes Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2013, 2018 and 2023) and long-term forecasts through 2028 and 2033 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Table of Contents

INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
BUSINESS ENVIRONMENT
  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties
DIABETES DRUGS INDUSTRY ASSESSMENTS
  • Diabetes Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Diabetes Drugs Industry Capacity
  • World Market Introduction
  • China Market Introduction
  • China Diabetes Development History
  • Major Producer Facility Locations, Output
  • Introduction of Some Diabetes Drugs
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development
IV.DIABETES DRUGS PRODUCTION AND DEMAND
  • Overview
  • Demand of Diabetes Drugs by Region
  • Diabetes Drugs Production and Demand
  • Insulin Medicines
  • Major Manufacturers
  • Supply and Demand
  • a-glucosidase Inhibitor Medicine
  • Major Manufacturers
  • Supply and Demand
  • Promoting Insulin Secretion Drugs
  • Major Manufacturers
  • Supply and Demand
  • Sulfonylurea Drugs
  • Major Manufacturers
  • Supply and Demand
  • Biguanides Drugs
  • Major Manufacturers
  • Supply and Demand
  • Digestives
  • Major Manufacturers
  • Supply and Demand
  • Insulin Sensitizer.
  • Major Manufacturers
  • Supply and Demand
  • Traditional Chinese medicine Drugs
  • Major Manufacturers
  • Supply and Demand
  • Diabetes Drugs Imports and Exports
  • Diabetes Drugs Imports
  • Diabetes Drugs Exports
  • Pricing Trend
DIABETES DRUGS MARKET OUTLOOK
  • Diabetes Drugs Market Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits
MARKETING STRATEGIES
  • China Market Entry Overview
  • China’s Distribution System
  • Anti Peptic Ulcer Drugs Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China’s Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises
DIABETES DRUGS PRODUCER DIRECTORY
  • Diabetes Drugs Producer Profiles
  • Distributors and Trading Companies
  • Research Institutions and Associations
LIST OF TABLES
INTRODUCTION
  • Economic Outlook Summary
BUSINESS ENVIRONMENT
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade
DIABETES DRUGS INDUSTRY ASSESSMENTS
  • Diabetes Drugs Industry Capacity
  • Diabetes Drugs Capacity, Output and Demand
  • Diabetes Drugs Production and Demand
  • Major Producer Facility Location
  • Major Diabetes Drugs Producer Output, Capacity and Market Share
  • Major Foreign Investment in China
DIABETES DRUGS PRODUCTION AND DEMAND
  • Diabetes Drugs Capacity and Demand
  • Diabetes Drugs Capacity and Growth Rate
  • Diabetes Drugs Capacity, Output and Demand and Growth Rate
  • Diabetes Drugs Output and Demand
  • Demand of Diabetes Drugs by Region
  • Insulin Medicines Production and Demand
  • a-glucosidase Inhibitor Medicines Production and Demand
  • Total Diabetes Drugs Production and Demand
  • Promoting Insulin Secretion Drugs Production and Demand
  • Sulfonylurea Production and Demand
  • Total Biguanides Production and Demand
  • Total Insulin Sensitizer Production and Demand
  • Traditional Chinese medicine Drugs Production and Demand
  • China Diabetes Drugs Imports
DIABETES DRUGS MARKET OUTLOOK
  • Total Diabetes Drugs Sales Volume by Market
  • Consumer Spending Trend
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits
LIST OF CHARTS
INTRODUCTION
  • Diabetes Drugs Production and Demand Summary
BUSINESS ENVIRONMENT
  • China's GDP and Industrial Output
  • Industrial Output by Ownership
  • Foreign Investments and Loans
DIABETES DRUGS INDUSTRY ASSESSMENTS
  • Diabetes Drugs Capacity in China
  • Diabetes Drugs Capacity, Output and DEMAND
DIABETES DRUGS PRODUCTION AND DEMAND
  • Total Diabetes Drugs Output and Demand
  • Total Diabetes Drugs Imports

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Tianjin Huajin Pharmaceutical Stock Co., Ltd,
  • Pfizer China